SCHEMBL22926449

SCHEMBL22926449

O=Cc1ccc(-c2ccc3c(cnn3CC3COC3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.36
MCHR1 Q99705 7/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
DGAT1 O75907 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK1 P28482 1/20 0.33
HDAC3 O15379 1/20 0.33
FASN P49327 4/20 0.32
ALDH1A2 O94788 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ALDH1A3 P47895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21998159 0.89 BRD4 (0.45) BRD4MCHR1HDAC1HDAC2RXRA
SCHEMBL22926448 0.88 BRD4 (0.44) BRD4MCHR1HDAC1HDAC2RXRA
SCHEMBL23807111 0.82 BRD4 (0.42) BRD4MCHR1HDAC1HDAC2RXRA
SCHEMBL30043816 0.78 MCHR1 (0.39) MCHR1CYP3A4CYP2C19ALDH1A1ALDH1A3
SCHEMBL23497968 0.78 MCHR1 (0.39) MCHR1CYP3A4CYP2C19ALDH1A1ALDH1A3
SCHEMBL30322550 0.76 MAPT (0.40) BRD4MCHR1HDAC1HDAC2MAPK1
SCHEMBL17390028 0.73 FASN (0.61) FASN
SCHEMBL21316122 0.71 FASN (0.44) MAPK1FASN
SCHEMBL22926182 0.70 HDAC1 (0.43) BRD4HDAC1HDAC2RXRARXRB
SCHEMBL28127752 0.68 WNT1 (0.38) BRD4MCHR1HDAC1HDAC2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 EP disclosed